Did you know ? If you order before Friday 14h we deliver 90PCT of the the time next Tuesday, GENTAUR another in time delivery

Pubmed ID :29312562
Publication Date : //

Downregulation of miR-221-3p and upregulation of its target gene PARP1 are prognostic biomarkers for triple negative breast cancer patients and associated with poor prognosis.


The purpose of this study was to identify microRNAs (miRNAs) closely associated with the prognosis of triple-negative breast cancer (TNBC) and their possible targets. This study recruited 125 early-stage TNBC patients, including 40 cases in the experimental group (20 cases with poor prognoses vs. 20 cases with good prognoses) and 85 cases in the validation group (27 cases with poor prognoses vs. 58 cases with good prognoses). In the experimental group, miRNA microarray showed 34 differentially expressed miRNAs in patients with different prognoses. We selected 5 miRNAs for validation. The differential expression of miR-221-3p was further verified in the experimental and validation groups using real-time polymerase chain reaction (PCR). High miR-221-3p expression was associated with better 5-year disease-free survival (DFS) (HR = 0.480; 95% CI, 0.263-0.879;= 0.017) of TNBC patients. High expression of its target genepredicted poorer 5-year DFS (HR = 2.236, 95% CI, 1.209-4.136,= 0.010). MiR-221-3p down-regulated PARP1 by targeting its 3'-untranslated region. In conclusion, low miR-221-3p expression may contribute to the poor outcome of TNBC patients through regulating. MiR-221-3p likely plays a role as a PARP1 inhibitor by directly regulating PARP1 expression, thereby affecting the prognoses of TNBC patients.

Authors : Deng Ling , Lei Qianqian , Wang Yu , Wang Zhu , Xie Guiqin , Zhong Xiaorong , Wang Yanping , Chen Nianyong , Qiu Yan , Pu Tianjie , Bu Hong , Zheng Hong ,

Related products :

Catalog number Product name Quantity
Breast - BRC481 Breast cancer array, 16 cases of breast cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
Breast - BRC1502 Breast cancer array, non_overlapping with BRC1501, consists of duplicated 70 cases covering all the common types of breast cancer and 5 cases of normal and other non_malignant breast tissues. 1.1mm
Breast - BRC961 Breast cancer array consists of duplicated 36 cases covering all the common types of breast cancer and 12 cases of normal and other non_malignant breast tissues. 1.5mm
Breast - BRC1501 Breast cancer array consists of duplicated 70 cases covering all the common types of breast cancer and 5 cases of normal and other non_malignant breast tissues. 1.1mm
Breast - BRC711 Breast cancer array, 71 cases of breast cancer, together with BRC491 forming the breast cancer array set. 1.1mm
Breast - BRC491 Breast cancer array, 49 cases of breast cancer, together with BRC711 forming the breast cancer array set. 1.7mm
MAB198P Mouse Monoclonal antibody Biomarkers, Collagen Triple Helix Repeat Containing 1 (Cthrc1)
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018
orb61216 AZD6244 Activating mutations in the BRAF gene, primarily at V600E, are associated with poorer outcomes in patients with papillary thyroid cancer. For research use only. 500 mg
BC08014 Breast cancer (multiple types of breast cancer) tissue array, 63 cases_63 cores, replaced by BR8018; ihc Anti-Actin confirmed
GI_Stomach - STC481 Stomach cancer tissue array, 16 cases of gastric cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
GI_Esophagus - ESC241 Esophagus cancer tissue array , 12 cases of esophageal cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2.5mm
1240 Breast cancer, matched metastatic carcinoma and cancer adjacent normal breast tissue array, including TNM, clinical stage and pathology grade, 48 cases_ 96 cores,
GI_Esophagus - ESC481 Esophagus cancer tissue array, non_overlapping with ESC241, 24 cases of esophageal cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients. Coming soon. 2mm
27-959 Fatty acid-binding protein 3 (FABP3) gene contains four exons and its function is to arrest growth of mammary epithelial cells. This gene is a candidate tumor suppressor gene for human breast cancer. 0.1 mg
1129 Breast cancer tissue array with lymph node positive and negative, including TNM, clinical stage and pathology grade, 98cases_ 110cores
Cervix - CXC241 Cervix cancer tissue array, 12 cases of cervical cancer paired with corresponding uninvolved tissues from the same patients 2.5mm
Endometrium - EMC241 Endometrium cancer tissue array, 12 cases of endometrial cancer paired with corresponding uninvolved tissues from the same patients 2.5mm
PBOV1_HUMAN ELISA Kit FOR Prostate and breast cancer overexpressed gene 1 protein; organism: Human; gene name: PBOV1 96T
Gl_Colon - COC481 Colon cancer tissue array, 16 cases of colon cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
Gl_Rectum - REC481 Rectum cancer tissue array, 16 cases of rectum cancer, each in duplicates, paired with corresponding uninvolved tissues from the same patients 2mm
BRCC3 BRCA3 Gene breast cancer 3
SCH-7863-2159 RABBIT ANTI HUMAN PROTEIN GENE PRODUCT 9.5 NEGATIVE CONTROL, Product Type Negative_Isotype Control, Specificity PROTEIN GENE PRODUCT 9.5 NEGATIVE CONTROL, Target Species Negative Control, Host Rab 50 µl
7863-2159 RABBIT ANTI HUMAN PROTEIN GENE PRODUCT 9.5 NEGATIVE CONTROL, Product Type Negative_Isotype Control, Specificity PROTEIN GENE PRODUCT 9.5 NEGATIVE CONTROL, Target Species Negative Control, Host Rab 50 µl
Urinary Bladder - BLC241 Bladder cancer tissue array, 12 cases of bladder cancer paired with corresponding uninvolved tissues from the same patients 2.5mm


 

GENTAUR Belgium BVBA BE0473327336
Voortstraat 49, 1910 Kampenhout BELGIUM
Tel 0032 16 58 90 45

Fax 0032 16 50 90 45
info@gentaur.com | Gentaur





GENTAUR Ltd.
Howard Frank Turnberry House
1404-1410 High Road
Whetstone London N20 9BH
Tel 020 3393 8531 Fax 020 8445 9411
uk@gentaur.com | Gentaur

 

 




GENTAUR France SARL
9, rue Lagrange, 75005 Paris
Tel 01 43 25 01 50

Fax 01 43 25 01 60
RCS Paris B 484 237 888

SIRET 48423788800017

BNP PARIBAS PARIS PL MAUBERT BIC BNPAFRPPPRG

france@gentaur.com | Gentaur

GENTAUR GmbH
Marienbongard 20
52062 Aachen Deutschland
Support Karolina Elandt
Tel: 0035929830070
Fax: (+49) 241 56 00 47 88

Logistic :0241 40 08 90 86
Bankleitzahl 39050000
IBAN lautet DE8839050000107569353
Handelsregister Aachen HR B 16058
Umsatzsteuer-Identifikationsnummer *** DE 815175831
Steuernummer 201/5961/3925
de@gentaur.com | Gentaur

GENTAUR U.S.A
Genprice Inc, Logistics
547, Yurok Circle
San Jose, CA 95123
CA 95123
Tel (408) 780-0908,
Fax (408) 780-0908,
sales@genprice.com

Genprice Inc, Invoices and accounting
6017 Snell Ave, Ste 357
San Jose, CA 95123




GENTAUR Nederland BV
NL850396268B01 KVK nummer 52327027
Kuiper 1
5521 DG Eersel Nederland
Tel:  0208-080893  Fax: 0497-517897
nl@gentaur.com | Gentaur
IBAN: NL04 RABO 0156 9854 62   SWIFT RABONL2U






GENTAUR Spain
tel:0911876558
spain@gentaur.com | Gentaur






ГЕНТАУЪР БЪЛГАРИЯ
ID # 201 358 931 /BULSTAT
София 1000, ул. "Граф Игнатиев" 53 вх. В, ет. 2
Tel 0035924682280 Fax 0035924808322
e-mail: Sofia@gentaur.com | Gentaur
IBAN: BG11FINV91501014771636
BIC: FINVBGSF

GENTAUR Poland Sp. z o.o.


ul. Grunwaldzka 88/A m.2
81-771 Sopot, Poland
TEL Gdansk 058 710 33 44 FAX  058 710 33 48              

poland@gentaur.com | Gentaur

Other countries

Österreich +43720880899

Canada Montreal +15149077481

Ceská republika Praha +420246019719

Danmark +4569918806

Finland Helsset +358942419041

Magyarország Budapest +3619980547

Ireland Dublin+35316526556

Luxembourg+35220880274

Norge Oslo+4721031366

Sverige Stockholm+46852503438

Schweiz Züri+41435006251

US New York+17185132983

GENTAUR Italy
SRL IVA IT03841300167
Piazza Giacomo Matteotti, 6
24122 Bergamo Tel 02 36 00 65 93
Fax 02 36 00 65 94
italia@gentaur.com | Gentaur